Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 100167
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.100167
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.100167
Figure 3 Prognostic factors influencing overall survival in third-line chemotherapy.
A: Performance status; B: Serum carbohydrate antigen 19-9 levels; C: Duration of second-line chemotherapy; D: Presence of peritoneal seeding were significantly associated with overall survival. PS: Performance status; CA19-9: Carbohydrate antigen 19-9; 2L: Second-line chemotherapy.
- Citation: Kim B, Kim J, Yang S, Ahn J, Jung K, Lee JC, Hwang JH. Identification of patients with advanced pancreatic cancer who might benefit from third-line chemotherapy. World J Gastrointest Oncol 2025; 17(2): 100167
- URL: https://www.wjgnet.com/1948-5204/full/v17/i2/100167.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.100167